Issues related to physician payment reform. Issues related to CMS reimbursement for radiopharmaceuticals.
2026 · 1st Quarter (Jan 1 - Mar 31)
SOCIETY OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
Filed by ARNOLD & PORTER KAYE SCHOLER LLP.
Open official filingSource-reported fields
Filing overview
- Type
- 1st Quarter - Report
- Posted
- Apr 20, 2026
- Income
- $60,000.00
- Expenses
- Not reported
- Registrant
- ARNOLD & PORTER KAYE SCHOLER LLP
- Filing UUID
- 8f9572e1-97d0-43ef-9e4c-65c46c088815
- Termination date
- Not reported
Literal source text
Lobbying issues and bill citations
Issues related to medical research funding. Issues related to theranostics report language in House Report 119-271 and Senate Report 119-55. Issues related to theranostics research within the Congressionally Directed Medical Research Programs (CDMRP).
Issues related to the Nuclear Regulatory Commission's preliminary proposed rule titled, "Reporting Nuclear Medicine Injection Extravasations as Medical Events" (10 CFR 35). Issues related to the Nuclear Medicine Clarification Act of 2025 (H.R. 2541).
Literal federal measure citations: H.R. 2541
Issues related to tariffs on nuclear medicines and radiopharmaceuticals.
Issues related to theranostics research within the Congressionally Directed Medical Research Programs (CDMRP).
Relationship and amount limits
Bill links use only the filing year’s mathematically derived Congress plus the literal measure type and number in the issue description. Unmatched citations remain plain text. Politically.com does not join on names, infer advocacy positions, combine amendments, or calculate totals across filings.